Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Payless Compounders, LLC recalls Semaglutide-Glycine-Cyanocobalamin Injectable

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • Semaglutide-Glycine-Cyanocobalamin Injectable
Company
Payless Compounders, LLC
Where it was sold

OR

States: Oregon

Units affected
91 vials
About this recall
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR